Company profileMixed portfolio#200 of 1,318 in Pakistan✓ No DRAP alerts

VEGA PHARMACEUTICALS LTD.

Mixed portfolio · 38 pharmaceutical brands of 90 registrations

Ranked #2 of 50 companies in Anti-Infective, Ophthalmologicals

90 registered products 38 pharmaceutical brands 77 distinct molecules 0 DRAP alerts

Part of this company's portfolio (“Eye”) is registered under a broad DRAP category rather than distinct molecules, so the molecule count understates its true range.

Company overview

registered products

pharmaceutical brands

distinct molecules

therapeutic classes

DRAP alerts

VEGA PHARMACEUTICALS LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 90 product registrations across 77 distinct molecules. It is the 200th largest registrant in Pakistan by product count, and ranks 2nd of 50 in Anti-Infective, Ophthalmologicals. Its portfolio is concentrated in Anti-Infective, Ophthalmologicals and Antiglaucoma Preparations And Miotics. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by VEGA

7 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Eye Conditions 7

Eyemox-D Eye5MlRs 399 Lubricanesterileopthalmic15mlRs 284.63 Olopat Eye0.1% 5mlRs 389.51 OlopateyeRs 389.51 Olopateye5mlRs 389.51 TimorexRs 103.5 VenacRs 290.95

Top molecules by brand count

Eye25 brands

Dexamethasone7 brands

Sodium Cromoglycate4 brands

Moxifloxacin4 brands

Tobramycin4 brands

Timolol3 brands

Ear3 brands

Isoconazole3 brands

Chloramphenicol3 brands

Gentamicin3 brands

Therapeutic classes

Conditions treated

Price band (DRAP official ceilings)

Registered products priced by source

DVAGO2 products · Rs 389.51 – Rs 420

Servaid7 products · Rs 103.5 – Rs 373.18

Median across source: Rs 404.75

Regulatory record

✓

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Atco Pharma International (Pvt) Ltd35 shared molecules

Sante (Private) Limited34 shared molecules

INNVOTEK PHARMACEUTICALS31 shared molecules

REMINGTON PHARMACEUTICAL INDUSTRIES (PVT) LTD.31 shared molecules

VALOR PHARMACEUTICALS30 shared molecules

HELIX PHARMA (PRIVATE) LIMITED28 shared molecules

Barrett Hodgson Pakistan (Private) Ltd.26 shared molecules

SHAIGAN PHARMACEUTICALS (PVT) LTD.25 shared molecules

JAENS PHARMACEUTICAL INDUSTRIES PVT LTD24 shared molecules

ALZA Pharma24 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Atco Pharma International (Pvt) Ltd holds 229 molecules not in this portfolio

Sante (Private) Limited holds 76 molecules not in this portfolio

INNVOTEK PHARMACEUTICALS holds 41 molecules not in this portfolio

Get the full profile for VEGA

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included